INTERVIEW: Eucomed ready to embrace EU regulatory change
This article was originally published in Clinica
Patients and industry alike need the EU medtech rules to change, and industry would do well to continue to closely follow the discussions between the Council and the European Parliament and prepare for changes ahead.
You may also be interested in...
Updated medtech notified body figures from the European Commission always make headline news. But industry needs to see real appointments now, not a list of tricky-to-understand numbers.
Erik Hansson remains deputy head of devices in a move to the European Commission’s DG Sante from DG Grow. He now answers to a newly appointed devices head who shares a common educational background but whose recent pharmaceutical role may unsettle the devices industry.
Companion diagnostics are needed increasingly by pharma companies to justify the safety and effectiveness of their products. With specific first-time EU regulation of these products within sight – and urgently needed – is there a risk of delays to these products being able to demonstrate compliance?